Venture Capital Investors

Clarus

Clarus makes VC investments in techn-focused companies.

Venture Investor Overview

Venture Investor
Clarus
Status
InActive
Investor Type
Venture Capital
Activity Level
Industry Focus
Biopharmaceutical

Contact Information

Contact
Nicholas Galakatos
Title
Managing Director
Mailing Address
101 Main St. 1210
Cambridge, MA 02142
USA
Email Address
Not Recorded

Background Information

Overview
Clarus is a leading global investment firm dedicated to life sciences and founded in 2005 by a team of accomplished investment and operating professionals. In every investment, Clarus employs a hands-on approach and leverages its scientific and clinical development expertise, as well as the ability to adapt to an ever-changing investment landscape. Clarus strives to generate outstanding returns for its investors by identifying and financing innovative medicines that improve people's lives.
Profile
Clarus LinkedIn Company Profile
Social Media
Clarus Company Twitter Account
Company News
Clarus News
Facebook
Clarus on Facebook
YouTube
Clarus on YouTube
Last Transaction
9/21/2018

Transaction History

Our records indicate that Clarus invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
9/21/2018
$150,000,000
2/2/2018
$60,000,000
10/18/2017
$75,000,000
9/8/2017
$92,700,000
9/6/2017
$31,900,000
6/17/2017
$32,000,000
8/9/2016
$37,000,000
8/3/2016
$25,000,000
6/23/2016
$44,000,000
6/3/2016
$15,500,000
5/2/2016
$44,500,000
4/6/2016
$34,000,000
4/5/2016
$50,000,000
3/31/2016
$4,821,000
10/21/2015
$102,000,000
9/30/2015
$8,800,000
7/14/2015
Unknown
3/31/2015
$12,414,000
12/16/2014
$34,000,000
11/13/2014
$40,000,000
11/4/2014
$26,500,000
8/7/2014
$8,500,000
12/31/2013
$5,000,000
12/31/2013
$22,767,000
11/14/2013
$32,400,000
6/28/2013
$21,000,000
3/31/2013
$13,000,000
3/31/2013
$41,726,900
3/31/2013
$8,750,000
12/31/2012
$500,000
12/3/2012
$15,300,000
11/13/2012
$65,000,000
9/30/2012
$21,000,000
9/30/2012
$8,800,000
6/30/2012
$35,000,000
5/23/2012
$25,000,000
3/29/2012
$65,000,000
12/13/2011
$8,000,000
11/7/2011
$20,000,000
10/11/2011
$42,000,000
9/30/2011
$23,000,000
8/3/2011
$41,000,000
7/18/2011
$44,000,000
3/31/2011
$12,017,000
1/5/2011
$23,000,000
12/7/2010
$20,000,000
10/19/2010
$69,000,000
8/23/2010
$10,000,000
8/11/2010
$32,000,000
7/14/2010
$50,000,000
6/17/2010
$12,000,000
5/4/2010
$5,000,000
4/28/2010
$11,000,000
4/21/2010
$39,600,000
2/1/2010
$15,000,000
1/27/2010
$30,000,000
12/31/2009
$4,000,000
10/29/2009
$47,750,000
9/23/2009
$51,000,000
6/9/2009
$30,000,000
5/12/2009
$26,000,000
4/16/2009
$36,000,000
3/16/2009
$45,000,000
1/12/2009
$25,000,000
11/5/2008
$8,400,000
10/6/2008
$60,000,000
9/30/2008
$7,000,000
9/30/2008
$38,000,000
9/30/2008
$5,000,000
9/30/2008
$40,000,000
7/3/2008
$18,000,000
6/30/2008
$20,000,000
2/28/2008
$25,000,000
2/1/2008
$65,000,000
1/9/2008
$18,000,000
12/31/2007
$7,000,000
12/6/2007
$89,000,000
9/30/2007
$15,000,000
9/6/2007
$15,500,000
8/23/2007
$110,000,000
6/30/2007
$15,000,000
4/18/2007
$85,000,000
3/27/2007
$32,000,000
2/7/2007
$35,000,000
1/5/2007
$37,500,000
12/31/2006
$25,000,000
9/28/2006
$50,000,000
8/29/2006
$60,000,000
8/2/2006
$41,000,000
5/4/2006
$60,000,000

 


Investor Contacts

Title
Name
Email & Social
Partner
Emmett Cunningham
  Emmett Cunningham LinkedIn Profile  Emmett Cunningham Twitter Account  Emmett Cunningham News  Emmett Cunningham on Facebook
Managing Director
Nicholas Galakatos
  Nicholas Galakatos LinkedIn Profile  Nicholas Galakatos Twitter Account  Nicholas Galakatos News  Nicholas Galakatos on Facebook
Partner
Barry Gertz
  Barry Gertz LinkedIn Profile  Barry Gertz Twitter Account  Barry Gertz News  Barry Gertz on Facebook
Managing Director
Dennis Henner
  Dennis Henner LinkedIn Profile  Dennis Henner Twitter Account  Dennis Henner News  Dennis Henner on Facebook
Managing Director
Robert Liptak
  Robert Liptak LinkedIn Profile  Robert Liptak Twitter Account  Robert Liptak News  Robert Liptak on Facebook
Managing Director
Scott Requadt
  Scott Requadt LinkedIn Profile  Scott Requadt Twitter Account  Scott Requadt News  Scott Requadt on Facebook
Managing Director
Nicholas Simon
  Nicholas Simon LinkedIn Profile  Nicholas Simon Twitter Account  Nicholas Simon News  Nicholas Simon on Facebook
Managing Director
Kurt Wheeler
  Kurt Wheeler LinkedIn Profile  Kurt Wheeler Twitter Account  Kurt Wheeler News  Kurt Wheeler on Facebook

 


Funds

Our database includes the following fund closing(s) for Clarus. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Clarus IV
5/17/2017
$910,000,000
Clarus Lifesciences III
6/19/2014
$500,000,000
Clarus Lifesciences II
2/25/2008
$660,500,000
Clarus Lifesciences I
12/6/2005
$500,000,000

 


Portfolio Companies

Clarus has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company

 

 


 

 

Browse more venture capital investors:

Clarium Capital | Class 5

 

Share this article

 


About Our VC Investors Database

This VC firm profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary